The system combines the newly developed solid state diode laser TopWave 229 and a spatial heterodyne spectrometer integrated into a single instrument with a unique all-reflective backscatter Raman collection probe. Sample damage caused by extended laser exposure has been mitigated via the introduction of a dynamic sample positioning stage.
The TopWave 229 is an exciting new choice for deep UV spectroscopists looking for a reliable laser that enables the user to focus on their application rather than worrying about the light source. With its short wavelength and an ultra-narrow laser linewidth (< 1 MHz ? < 4 x 10-5 cm-1), the TopWave 229 offers the critical features to meet a challenge such as excitation source in the field of deep UV Raman and deep UV fluorescence spectroscopy.
It was designed for a compact footprint and easy integration. Comfortable, hands-off operation is ensured by fully automated optimization routines for the internal opto-mechanics. In order to provide best reliability and consistent, diffraction limited beam quality (M² ? 1.3) the complete UV beam path is enclosed in a specially sealed compartment.
With its state-of-the-art laser controller, the TopWave 229 offers a wide range of operating options and systems integrators will appreciate the comprehensive command language that enables smooth integration with central control software.
A general description of the instrument is provided by Michael Foster, William Brooks (both IS-I) and Philipp Jahn (TOPTICA) in this white paper.
The technical report describes a new deep UV Raman instrument developed by IS-Instruments (ISI) and TOPTICA, and its first application to the measurement of biopharma products. The instrument performance is excellent acquiring spectra in a fraction of the time compared to existing systems, while its stability, compactness and ease of use are a game changer in terms of deep UV systems. In this note, a general description of the instrument is provided together with a test campaign examining products including IgG and antibody fragments.
The instrument has been demonstrated to successfully capture the Raman spectra of a range of biochemical samples, including immunoglobulin (IgG) at varying concentrations, tryptophan, and a series of domain antibody (dAb) samples. The dAb samples were extracted at different stages of a pilot bioreactor manufacturing process and at varying dilutions. To the knowledge of the authors, this is the first time an observation of this type has been made.
@CsiInstruments @TOPTICA_AG #Pharma
No comments:
Post a Comment